IMPORTANCE OF PRECISE POSITIONING FOR PROTON-BEAM THERAPY IN THE BASE OF SKULL AND CERVICAL-SPINE

被引:16
作者
TATSUZAKI, H
URIE, MM
机构
[1] HARVARD UNIV,MASSACHUSETTS GEN HOSP,DEPT RADIAT MED,BOSTON,MA 02114
[2] HARVARD UNIV,SCH MED,BOSTON,MA 02115
来源
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 1991年 / 21卷 / 03期
关键词
PROTON THERAPY; COMPARATIVE TREATMENT PLANNING; PRECISE POSITIONING; PATIENT IMMOBILIZATION; NORMAL TISSUE COMPLICATION PROBABILITY MODELS; TUMOR CONTROL PROBABILITY MODELS;
D O I
10.1016/0360-3016(91)90696-2
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Using proton beam therapy, high doses have been delivered to chordomas and chondrosarcomas of the base of skull and cervical spine. Dose inhomogeneity to the tumors has been accepted in order to maintain normal tissue tolerances, and detailed attention to patient immobilization and to precise positioning has minimized the margins necessary to ensure these dose constraints. This study examined the contribution of precise positioning to the better dose localization achieved in these treatments. Three patients whose tumors represented different anatomic geometries were studied. Treatment plans were developed which treated as much of the tumor as possible to 74 Cobalt-Gray-Equivalent (CGE) while maintaining the central brain stem and central spinal cord at less-than-or-equal-to 48 CGE, the surface of the brain stem, surface of the spinal cord, and optic structures at less-than-or-equal-to 60 CGE, and the temporal lobes at less-than-or-equal-to 5% likelihood of complication using a biophysical model of normal tissue complication probability. Two positioning accuracies were assumed: 3 mm and 10 mm. Both proton beam plans and 10 MV X ray beam plans were developed with these assumptions and dose constraints. In all cases with the same positioning uncertainties, the proton beam plans delivered more dose to a larger percentage of the tumor volume and the estimated tumor control probability was higher than with the X ray plans. However, without precise positioning both the proton plans and the X ray plans deteriorated, with a 12% to 25% decrease in estimated tumor control probability. In all but one case, the difference between protons with good positioning and poor positioning was greater than the difference between protons and X rays, both with good positioning. Hence in treating these tumors, which are in close proximity to critical normal tissues, attention to immobilization and precise positioning is essential. With good positioning, proton beam therapy permits higher doses to significantly more of the tumor in these sites than do X rays.
引用
收藏
页码:757 / 765
页数:9
相关论文
共 50 条
  • [21] A systematic review of proton therapy in the treatment of chondrosarcoma of the skull base
    Amichetti, Maurizio
    Amelio, Dante
    Cianchetti, Marco
    Enrici, Riccardo Maurizi
    Minniti, Giuseppe
    [J]. NEUROSURGICAL REVIEW, 2010, 33 (02) : 155 - 165
  • [22] A systematic review of proton therapy in the treatment of chondrosarcoma of the skull base
    Maurizio Amichetti
    Dante Amelio
    Marco Cianchetti
    Riccardo Maurizi Enrici
    Giuseppe Minniti
    [J]. Neurosurgical Review, 2010, 33 : 155 - 165
  • [23] Ectopic Recurrence of Skull Base Chordoma after Proton Therapy
    Santegoeds, Rene G. C.
    Alahmari, Mohammed
    Postma, Alida A.
    Liebsch, Norbert J.
    Weber, Damien Charles
    Mammar, Hamid
    Eekers, Danielle B. P.
    Temel, Yasin
    [J]. CURRENT ONCOLOGY, 2022, 29 (04) : 2364 - 2375
  • [24] Investigation of ectopic recurrent skull base and cervical chordomas: The Institut Curie's Proton Therapy Center experience
    Vogin, Guillaume
    Calugaru, Valentin
    Bolle, Stephanie
    George, Bernard
    Oldrini, Guillaume
    Habrand, Jean-Louis
    Mammar, Hamid
    Dendale, Remi
    Salleron, Julia
    Noel, Georges
    Feuvret, Loic
    [J]. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2016, 38 : E1238 - E1246
  • [25] Comparison Between Two and Three Beam Intensity Modulated Proton Therapy (IMPT) Plans for Base of Skull Chordomas
    Yeager, C.
    Lichtenwalner, P.
    Teo, B.
    Alonso-Basanta, M.
    Kassaee, A.
    [J]. MEDICAL PHYSICS, 2013, 40 (06)
  • [26] Outcomes of adolescents and young adults treated for brain and skull base tumors with pencil beam scanning proton therapy
    Lim, Pei S.
    Tran, Sebastien
    Kroeze, Stephanie G. C.
    Pica, Alessia
    Hrbacek, Jan
    Bachtiary, Barbara
    Walser, Marc
    Leiser, Dominic
    Lomax, Antony J.
    Weber, Damien C.
    [J]. PEDIATRIC BLOOD & CANCER, 2020, 67 (12)
  • [27] Dosimetric comparison of gantry and horizontal fixed-beam proton therapy treatment plans for base of skull chordoma
    Shierlaw, Emma
    Penfold, Melanie
    Crain, Rosanna
    Santos, Alexandre M. C.
    Penfold, Scott N.
    [J]. JOURNAL OF MEDICAL RADIATION SCIENCES, 2024, 71 : 19 - 26
  • [28] Proton Therapy for Skull Base Chordomas: An Outcome Study from the University of Florida Proton Therapy Institute
    Deraniyagala, Rohan L.
    Yeung, Daniel
    Mendenhall, William M.
    Li, Zuofeng
    Morris, Christopher G.
    Mendenhall, Nancy P.
    Okunieff, Paul
    Malyapa, Robert S.
    [J]. JOURNAL OF NEUROLOGICAL SURGERY PART B-SKULL BASE, 2014, 75 (01) : 53 - 57
  • [29] Cost-effectiveness of proton therapy in treating base of skull chordoma
    Austin, Annabelle M.
    Douglass, Michael J. J.
    Nguyen, Giang T.
    Dalfsen, Raymond
    Le, Hien
    Gorayski, Peter
    Tee, Hui
    Penniment, Michael
    Penfold, Scott N.
    [J]. AUSTRALASIAN PHYSICAL & ENGINEERING SCIENCES IN MEDICINE, 2019, 42 (04) : 1091 - 1098
  • [30] Cost-effectiveness of proton therapy in treating base of skull chordoma
    Annabelle M. Austin
    Michael J. J. Douglass
    Giang T. Nguyen
    Raymond Dalfsen
    Hien Le
    Peter Gorayski
    Hui Tee
    Michael Penniment
    Scott N. Penfold
    [J]. Australasian Physical & Engineering Sciences in Medicine, 2019, 42 : 1091 - 1098